A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP and MVA ME-TRAP.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Malaria vaccine (Primary)
- Indications Malaria
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 21 Mar 2012 Additional lead trial centre identified as reported by United Kingdom Clinical Research Network record.
- 21 Mar 2012 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
- 28 Mar 2011 Biomarkers information updated